Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.48 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | TACR1 | P25103 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.35 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8656680 | 0.93 | ALB (0.44) | ALBSLC6A9S1PR1SIGMAR1SLC6A3 | |
| SCHEMBL883651 | 0.91 | ALB (0.42) | ALBSLC6A9S1PR1SIGMAR1SLC6A3 | |
| SCHEMBL10305290 | 0.90 | ALB (0.42) | ALBSLC6A9S1PR1FOLH1 | |
| SCHEMBL4368905 | 0.87 | ALB (0.40) | ALBSLC6A9S1PR1SIGMAR1SLC6A3 | |
| SCHEMBL9877605 | 0.86 | LMNA (0.49) | ALBSLC6A9S1PR1SLC6A3TACR1 | |
| SCHEMBL4366090 | 0.85 | ALB (0.39) | ALBSLC6A9S1PR1SIGMAR1TACR1 | |
| SCHEMBL24507414 | 0.84 | MMP12 (0.47) | ALBSLC6A9S1PR1SIGMAR1SLC6A3 | |
| SCHEMBL17986179 | 0.83 | KCNJ1 (0.50) | ALBSIGMAR1SLC6A3KDM4EPOLB | |
| SCHEMBL8657520 | 0.83 | KCNJ1 (0.50) | ALBSIGMAR1SLC6A3KDM4EPOLB | |
| SCHEMBL16922663 | 0.81 | ALB (0.44) | ALBSLC6A9S1PR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025122615-A1 | ENRICHED AND STABLE RADIOLIGAND THERAPY FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | MARIANA ONCOLOGY INC. (US) | 2025-06-12 | — | — | WO | claimed |
| US-20240352199-A1 | METHOD FOR PREPARATION OF FIXED SWELLABLE POLYMER | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2024-10-24 | — | — | US | claimed |
| EP-4408484-A1 | MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY | Antelope Surgical Solutions, Inc. (US) | 2024-08-07 | — | — | EP | claimed |
| CN-118338916-A | Multifunctional compounds for use in medical imaging and therapy | 安特络手术解决方案公司 | 2024-07-12 | — | — | CN | claimed |
| EP-4389804-A1 | METHOD FOR PREPARING SWELLABLE POLYMER TO WHICH OBJECT IS FIXED | Pusan National University Industry-University Cooperation Foundation (KR) | 2024-06-26 | — | — | EP | claimed |
| CN-118019782-A | Method for producing object-immobilized swellable polymer | 釜山大学校产学协力团 | 2024-05-10 | — | — | CN | claimed |
| CN-116970033-A | Enzymatic self-assembled molecular probe, preparation method and application thereof | 江苏省原子医学研究所 | 2023-10-31 | — | — | CN | claimed |
| US-20230256122-A1 | COMBINATION THERAPY FOR TREATING CANCER | CITY OF HOPE | 2023-08-17 | — | — | US | claimed |
| US-20230149569-A1 | MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY | ANTELOPE SURGICAL SOLUTIONS, INC. | 2023-05-18 | — | — | US | claimed |
| WO-2023056221-A1 | MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY | ANTELOPE SURGICAL SOLUTIONS, INC. (US) | 2023-04-06 | — | — | WO | claimed |
| US-5652361-A | ANTITUMOR | THE DOW CHEMICAL COMPANY (US) | 1997-07-29 | — | — | US | claimed |
| EP-0662842-A1 | PROCESS FOR PREPARING MACROCYCLIC CHELATING AGENTS AND FORMATION OF CHELATES AND CONJUGATES THEREOF | THE DOW CHEMICAL COMPANY (US) | 1995-07-19 | — | — | EP | claimed |
| EP-0353450-B1 | Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates | DOW CHEMICAL CO (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1993020852-A2 | MACROCYCLIC CHELATING AGENTS, CHELATES AND CONJUGATES THEREOF | THE DOW CHEMICAL COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| US-5133956-A | Radiolabeled metal-binding protein for the treatment of arthritis | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | claimed |
| EP-0420942-A1 | MACROCYCLIC BIFUNCTIONAL CHELANTS, COMPLEXES THEREOF AND THEIR ANTIBODY CONJUGATES | THE DOW CHEMICAL COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| WO-1990007342-A1 | PROCESS FOR PREPARING ISOTHIOCYANATO FUNCTIONALIZED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 1990-07-12 | — | — | WO | claimed |
| EP-0374947-A1 | Process for preparing isothiocyanato functionalized metal complexes | THE DOW CHEMICAL COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
| EP-0353450-A1 | Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates | THE DOW CHEMICAL COMPANY (US) | 1990-02-07 | — | — | EP | claimed |
| WO-1989012631-A1 | MACROCYCLIC BIFUNCTIONAL CHELANTS, COMPLEXES THEREOF AND THEIR ANTIBODY CONJUGATES | THE DOW CHEMICAL COMPANY (US) | 1989-12-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149569-A1 | MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY | PAICS, BID, OGFR | ALB 104/4885SLC6A9 4116/4885S1PR1 473/4885 |
| US-20230256122-A1 | COMBINATION THERAPY FOR TREATING CANCER | IL2, IL2RA, IL15 | ALB 138/4885SLC6A9 4133/4885S1PR1 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.